|
| |
Celgene CorporationCelgene is a pharmaceutical company with a major focus on the discovery, development and commercialization of small molecules for cancer and immunological diseases.Celgene's medical research and development team is working to extend the boundaries in the areas of small molecule immunotherapeutic and biocatalytic chiral chemistry by developing both new pharmaceuticals and chirally pure versions of existing drugs. Celgene's agrochemical unit, Celgro, is dedicated to the development of chirally pure crop protection agents.
Our goal is to provide hope and ease suffering through the discovery and development of products for therapies for patients with severe and difficult to treat diseases.
| Contact Details: |
| 86 Morris Avenue |
| Summit |
| NJ |
| 07901 |
| United States of America |
| Tel: | 1-908-673-9000 |
| Fax: | 908 271 4184 |
| Email: | |
| WWW: | www.celgene.com/
|
|
Loading...
|
Recent Publications by Celgene Corporation: |  |
Survival Effect of Venous Thromboembolism in Patients With Multiple Myeloma Treated With Lenalidomide and High-Dose Dexamethasone.
PURPOSE: We conducted a retrospective analysis of the survival effect of... | 11th November, 2009
| Division of Hematology, Blood/Marrow Transplant and Myeloma Program,
| J Clin Oncol. 2009 Nov 9.
DOI Direct Link |
Pomalidomide and lenalidomide induce p21 WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism.
Lenalidomide and pomalidomide have both been evaluated clinically for... | 8th October, 2009
| Celgene, San Diego, California 92121, USA.
| Cancer Res. 2009 Sep 15;69(18):7347-56. Epub 2009 Sep 8.
DOI Direct Link |
Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma.
PURPOSE: Lenalidomide and bortezomib are active in relapsed and... | 30th September, 2009
| Department of Medical Oncology, Dana-Farber Cancer Institute; and Beth
| J Clin Oncol. 2009 Nov 9.
DOI Direct Link |
Determination of the residual ethanol in hydroalcoholic sealed hard gelatin capsules by static headspace gas chromatography with immiscible binary solvents.
Static headspace gas chromatography (HS-GC) with immiscible binary... | 11th September, 2009
| Analytical Research and Development, Celgene Corporation, Summit, NJ
| J Chromatogr A. 2009 Apr 10;1216(15):3328-36. Epub 2009 Feb 21.
DOI Direct Link |
Thalidomide chemotherapy-induced peripheral neuropathy: actual status and new perspectives with thalidomide analogues derivatives.
IMiDs compounds are a class of analogues of thalidomide, with greater... | 20th August, 2009
| Medical Department, Celgene S.r.l., Corso Garibaldi 86 - 20121 Milano,
| Mini Rev Med Chem. 2009 Jun;9(7):760-8.
|
→View more Celgene Corporation research publications. |
Press Releases on Celgene Corporation:
|
 |
| Reportlinker Adds Anticoagulants - A Global Market Review |
18th November, 2009 |
Reportlinker |
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Anticoagulants - A Global Market Review
http://www.reportlinker.com
|
| Reportlinker Adds Global Stem Cell and Advanced Technologies Market |
10th November, 2009 |
Reportlinker |
-- Stem Cell Applications (regenerative medicine - neurological disorders,
orthopedics, cancer, hematological disorders, myocardial infarction and
cardiovascular diseases,
|
| Alexandria Real Estate Equities, Inc. Provides Update |
29th October, 2009 |
Alexandria Real Estate Equities, Inc. |
PASADENA, Calif., Oct. 29 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), Landlord of Choice to the Life Science Industry®, today provided an update highlighting recent
|
| Updated NCCN Guidelines for AML Include Risk Stratification to Assist in Treatment Selection |
19th October, 2009 |
National Comprehensive Cancer Network |
The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Acute Myeloid Leukemia (AML), the most common acute leukemia affecting adults. Noteworthy updates include the
|
| Prix Galien USA Announces 2009 Final Candidates |
7th August, 2009 |
Prix Galien USA |
-- Wyeth, TORISEL(R)
Best Biotechnology Product:
-- Amgen, Nplate(R)
-- GlaxoSmithKline, PROMACTA(R) and Tykerb(R)
-- Schering-Plough, PEGINTRON(R)
-- Tibotec, INTELENCE(TM
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 20 individuals from Celgene Corporation using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 3488 times since April 2007, the link to the organisation's website has been followed 370 times Recent Search Terms used to find this page: celgene pharmaceuticals | celgene usa | celgene pharmaceuticals | celgene pharmaceuticals oncology | working in celgene | celgene pharmaceuticals | celgene pharmaceuticals | celgene pharmaceuticals | celgane | celgene pharmaceuticals | . Search for more companies in Summit Search for more companies in NJ This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Celgene Corporation |
